ReviewTherapeutic advances in neurological disorders2026

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis.

Krzysztof Selmaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.